baber/WOPTO huggingface dataset:
Patent DK-0644183-T3 (DK)
Inventor: MASUMOTO KATUHISA
IPC: C07C251/48
Filed: 1994-09-15
Granted: 1999-11-15
Abstract: There is disclosed a process of producing an N-alkylacetamide of the general formula (III): <CHEM> wherein X<1>, X<2> and X<3> are the same or different and are independently hydrogen, lower alkyl, lower alkoxy, lower alkenyl, halogen or trifluoromethyl; R<1> and R<2> are the same or different and are independently lower alkyl; and  @  represents a chemical bond of E- or Z-configuration, or a mixture of these configurations, which includes the steps of:     (a) reacting an acetonitrile of the general formula (I): <CHEM> wherein X<1>, X<2>, X<3>, R<1> and  @  are each as defined above, with an alkylamine of the general formula (IV):    R<2>-NH2   (IV> wherein R<2> is as defined above, to give an N-alkylacetamidine of the general formula (II): <CHEM> wherein X<1>, X<2>, X<3>, R<1>, R<2> and  @  are each as defined above; and (b) reacting the N-alkylacetamidine (II) with a nitrite derivative in the presence of an acid.
Patent DK-0635261-T3 (DK)
Inventor: BONILLA MUNOZ ANGEL
IPC: A61K9/52
Filed: 1994-07-19
Granted: 1999-10-18
Abstract: The preparation consists of millispheres, micro-spheres, nanospheres or array-type particles consisting of a nucleus of a gellable hydrocolloid onto which has been deposited a film of a cationic polysaccharide, and incorporating inside a pharmacologically useful drug. The procedure consists of dissolving, suspending or emulsifying the drug in a solution of the gellable hydro-colloid; adding the resulting mixture to a gelling solution; and suspending the resulting millispheres, micro-spheres, nanospheres or array-type particles in a solution of the cationic polysaccharide. <IMAGE>
Patent DK-0655062-T3 (DK)
Inventor: HANSON GUNNAR J
IPC: C07D295/12
Filed: 1993-08-13
Granted: 1998-05-18
Abstract: Compounds characterized generally as oxazopinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I    <IMAGE>  (I)  wherein A is selected from CO and SO2; wherein X is selected from oxygen atom and methylene; wherein B is an oxazopinyl group; wherein R1 is selected from hydrido, methyl, ethyl, isopropyl and n-propyl; wherein R2 is phenylmethyl; wherein each of R3 and R5 is hydrido; wherein R4 is selected from -(CH2)q-C 3BOND C-V wherein V is selected from hydrido and methyl; wherein R6 is cyclohexylmethyl; wherein R7 is selected from isobutyl, cyclopropyl and cyclopropylmethyl; wherein q is a number selected from zero through three, inclusive; and wherein n is a number selected from zero through three, inclusive; or a pharmaceutically-acceptable salt thereof.
Patent DK-0705942-T3 (DK)
Inventor: HAUER JEAN-CLAUDE
IPC: E02D29/14
Filed: 1995-10-05
Granted: 2001-02-12
Abstract: The cover consists of a surrounding frame (5) and a hinged lid (7). The hinge is equipped with a cam (29) which interacts with a counter-cam (22) on the frame to align the adjacent edges of the lid and frame when the lid is closed. The lid and frame also have interacting lateral guide surfaces, and the lid has an anti-lift pin (30) on each side adjacent to its hinge to prevent its hinge end from lifting when closed.
Patent DK-0678092-T3 (DK)
Inventor: OLMSTEAD THOMAS A
IPC: C07D487/04
Filed: 1994-10-31
Granted: 2000-05-08
Abstract: 2-Chlorosulfonyl-5-alkoxy[1,2,4]triazolo-[1,5-c]pyrimidine compounds, such as 2-chlorosulfonyl-5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidine, that are useful for the preparation of 5-alkoxy[1,2,4]triazolo [1,5-c]pyrimidine-2-sulfonamide herbicides, were prepared in an improved manner from 5-alkoxy[1,2,4]triazolo [1,5-c]pyrimidine-2(3H)-thione compounds, such as 5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione, by oxidation with hydrogen peroxide to obtain novel 2,2'-dithiobis(5-alkoxy[1,2,4]triazolo[1,5-c]pyrimidine) compounds, such as 2,2'-dithiobis (5-ethoxy-7-fluoro[1,2,4]triazolo[1,5-c]pyrimidine), and subsequent chloroxidation of these intermediate compounds.
Patent DK-0679092-T3 (DK)
Inventor: RICHARD A HOUGHTEN
IPC: A61K38/08
Filed: 1994-11-09
Granted: 1999-11-08
Abstract: The present invention provides novel cytokine restraining agents, which limit or control the biological activity of cytokines. The invention also provides pharmaceutical compositions comprising a cytokine restraining peptide and methods of administering the pharmaceutical composition to a subject. The invention further provides methods for using the novel peptides to restrain cytokine activity in a subject.
Patent DK-0754260-T3 (DK)
Inventor: DAEHLING PAUL-HEINZ
IPC: D21H21/52
Filed: 1995-04-07
Granted: 1999-02-08
Abstract: PCT No. PCT/EP95/01283 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Apr. 7, 1995 PCT Pub. No. WO95/27824 PCT Pub. Date Oct. 19, 1995A web printing paper, including a coating base paper which contains mineral filler and at least one of wood pulp and cellulose as fiber components. The coating base paper has a grammage of 30 to <58 g/m2, and a filler content, relative to its grammage, equal to 15 to 35% by weight. The coating base paper selectively contains, in addition to the at least one of wood pulp and cellulose, up to <50% by weight recycled fibers, all weight parts adding up to 100% by weight. The printing paper further includes a coating applied to both sides of the base paper by a film press so as to absorb printing ink. The coating contains pigment and binder. The coating on each side of the base paper has a grammage of 2 to 12 g/m2, and the pigment of the coating has a grain size, 40 to 60% by weight, of <2  mu m.
Patent DK-0785794-T3 (DK)
Inventor: SUGG ELIZABETH ELLEN
IPC: C07D405/12
Filed: 1995-10-13
Granted: 2002-03-18
Abstract: A pharmaceutical formulation in solid dosage form for oral administration which comprises a compound of general formula (I) or a physiologically salt thereof together with one or more pharmaceutically acceptable carriers wherein the formulation is encased in an enteric coating or capsule.
Patent DK-0780279-T3 (DK)
Inventor: ELSNER HELMUT DR
IPC: B61D17/04
Filed: 1996-12-17
Granted: 1999-11-15
Abstract: The trough-shaped body (22) comprises a floor (22), on which are sidewalls (34) consisting of uprights (30) and top and bottom lengthwise beams (28, 26) forming a latticework structure. The top beams are supported by connecting beams forming sidewalls, windows and doorways (16, 18). The uprights are in a zigzag pattern and are secured by stiff joints to the beams. The mouldings (40) and bars (50) forming the body are glued together, and after the glue has set the cladding and windows are installed using the thick-layer (sic) gluing method. The mouldings can form nodal points with the bars fitted to them, the gaps (52) between their mating faces being filled with glue. The mouldings can be cast or forged, and of aluminium alloy. The floor can be of corrugated sheet-metal with transverse beams transmitting the load to the sidewalls and bottom beams.
Patent DK-0736489-T3 (DK)
Inventor: PRAT EVELYNE
IPC: C04B28/02
Filed: 1996-04-01
Granted: 1998-11-16
Abstract: New aq. suspensions of silica and an Al cpd. chosen from the sulphate, basic sulphate, an alum. of a mixt. have a pH less than 4 and a dry material content of 10-50% wt. After standing for 48 hrs. they form gels which are reversible at a low shear rate. Also claimed are their prepn. and use. The prodn. are used in cement compsns., based on cement and water, mortars and concrete, the prepn. of paper pulps, in water treatment and as constituents of mineral glues for paper-cartons and in construction materials. The new prodn., containing precipitated SiO2 and an Al sulphate. They have a tendency to form gels on standing, thus avoiding sedimentation or sepn. on storage. The suspensions are stable for weeks or even months. The gels formed are totally reversible, reverting to a homogeneous suspension, with light stirring, of low viscosity and easy pumpability.
Patent DK-0759785-T3 (DK)
Inventor: TOURNIER HERVE
IPC: A61K49/18
Filed: 1996-02-22
Granted: 2002-02-18
Abstract: The present invention concerns injectable blood pool contrast agents for NMR and X-ray imaging purpose. These blood pool agents carry imaging contrast enhancers, e.g. paramagnetic or, respectively, radio-opaque compounds for imaging the circulation and/or circulation targeted organs. The blood pool agent compositions are formulated to protect the contrast agents from early removable by the reticulo-endothelial (RES) system of the liver and the spleen, so that they stay in the circulation long enough to provide good images of the blood vessels and blood perfused organs. X-ray and NMR imaging of the circulation and of targeted organs can strongly assist in diagnosing possible ailments in human and animal patients.
Patent DK-0824405-T3 (DK)
Inventor: DAMES ANDREW
IPC: G07D7/04
Filed: 1996-05-10
Granted: 2000-06-13
Abstract: Articles for use with security documents are disclosed which include planchettes and security threads that comprise a plastic substrate having at least one security feature employing soft magnetic metal located thereon. Preferred articles comprise at least two security features where a first security feature is made up of an optionally repeating pattern of soft magnetic metal adapted to generate a signal or a series of signals in an interrogation field applied by a detection system for remote detecting and optionally for remote reading or identifying the article. A second security feature is a public security feature that comprises magnetic and/or non-magnetic metal formed indicia. The first and second security features of this invention can be coextensive features.
Patent DK-0883342-T3 (DK)
Inventor: LITERATI NAGY PETER
IPC: A01N43/40
Filed: 1996-12-20
Granted: 2002-02-04
Abstract: Compositions containing hydroximic acid derivatives of the formulawhere R1, R2, R3, R, X, Y, A, and B are as defined in the specification, are useful for the promotion of plant production and/or for the elimination of unfavourable environmental influences in plant cultivation.
Patent DK-0779508-T3 (DK)
Inventor: GRUNDFEST WARREN S
IPC: G01N33/66
Filed: 1994-04-01
Granted: 2003-10-20
Abstract: A glucose monitor, and related method, determines the concentration of glucose in a sample by monitoring fluorescent light produced directly by any glucose present in the sample. The glucose monitor illuminates the sample with ultraviolet excitation light that induces any glucose present in the sample to fluoresce, with the fluorescent light being monitored and processed to determine the concentration of glucose in the sample. A sensor monitors the return light, which includes fluorescent light produced by any glucose in the sample, and generates first and second electrical signals indicative of the intensity of light in two wavelength bands. One wavelength band includes a characteristic spectral peak of glucose fluorescence, and the other wavelength band is a reference band having known spectral characteristics. A processor then processes the first and second electrical signals to determine the concentration of glucose in the sample. A fiber-optic waveguide is used to guide the excitation light from the laser light source to the sample and the return light from the sample to the sensor. The fiber-optic waveguide is housed in a catheter or probe that is adapted to monitor the concentration of glucose percutaneously in the oral cavity tissues of a person's mouth such as the gums. <IMAGE>
Patent DK-0816377-T3 (DK)
Inventor: BUETTNER JOSEPH A
IPC: C12N9/74
Filed: 1997-06-16
Granted: 2002-07-22
Abstract: Peptide ligands which bind to thrombin and prothrombin are disclosed. The sequences of these peptides are Gln-Leu-Trp-Gly-Ser-His, Arg-Gln-Leu-Trp-Gly-Ser-His, His-Gln-Leu-Trp-Gly-Ser-His, and Tyr-Phe-Pro-Gly-Pro-Tyr-Leu. The preferred peptides have the sequence Gln-Leu-Trp-Gly-Ser-His or Tyr-Phe-Pro-Gly-Pro-Tyr-Leu. A method of using these peptides in an affinity chromatography process to purify thrombin is described.
Patent DK-0822012-T3 (DK)
Inventor: DEROCH MAXIME
IPC: B05D7/16
Filed: 1997-07-23
Granted: 2004-04-13
Abstract: Coated metallic surface comprises, successively from metal, at least one layer of polyurethane; and at least one layer of thermoplastic polymer; with a binder between the two layers. Also claimed is method for coating surface and device comprising bundle of steel strands with the coating.
Patent DK-0893715-T3 (DK)
Inventor: HUSSEY CONLETH D
IPC: G02B6/34
Filed: 1997-07-21
Granted: 2004-06-14
Abstract: To form an optical element (20), in particular an interferometric sensor, an optical fiber (1) is placed tangent to a cylindrical supporting element (2); a straight portion (1a) of the optical fiber and the supporting element are surface fused; and a cavity (26) is formed in the optical fiber (1), the cavity being defined by facing surfaces (27, 28) of the straight portion (1a) substantially perpendicular to the axis of the straight portion (1a). The optical fiber (1) and supporting element (2) may also be subjected to traction during surface fusion, to form a small-cross-section portion close to the cavity, and which, when light is conducted by the optical element, provides for reducing the amount of light dispersed in the cavity. <IMAGE>
Patent DK-0890030-T3 (DK)
Inventor: BRITZ WOLFGANG
IPC: F15B20/00
Filed: 1997-01-17
Granted: 2002-09-23
Abstract: The invention relates to a safety circuit for controlling a hydraulic drive (10) with a drive part (12) movable in at least two different directions of movement and controllable for any movement  by a control switching circuit. A safety circuit which ensures the required safety function in an absolutely safe manner, even in the event of a power failure, is obtained in that at least one safety switching circuit is hydraulically combined with the control switching circuit in such a manner that when the latter is switched off the drive part (12) can only be controlled by the respective safety switching circuit. Consequently, the highest-priority operation provided in an emergency, for example in the form of the defined closing or opening of a vapour control valve, is safely executed and the otherwise usual control process is interrupted by the control switching circuit.
Patent DK-0900298-T3 (DK)
Inventor: VIELUF HANS-DIETER
IPC: D06N1/00
Filed: 1997-05-16
Granted: 2003-03-03
Abstract: A floorcovering tile is provided which has an upper and a lower layer and a carrier arranged between these, where at least one of the two layers is a service layer. The floorcovering tile retains its flatness even when temperature and/or humidity varies. A process for producing the floorcovering tile is also described.
Patent DK-0916055-T3 (DK)
Inventor: BARBE PIERRE
IPC: F16L27/11
Filed: 1997-08-01
Granted: 2001-07-09
Abstract: This device for jump jointing piping elements (10, 12) having relative movements at least along one direction, comprises a sealing sleeve tube (16) made of deformable plastic material to be sealingly fixed on the end zones opposite said piping elements. It further comprises a pipe lining (24) forming piping element located in the sleeve tube (16) with its opposite end zones (26, 28) mounted each in a piping element (10, 12) with clearance for absorbing the relative displacements of said piping elements, said pipe lining (24) comprising an intermediate portion (30) extending between its end zones (26, 28) and defining externally a supporting surface for said sleeve tube (16).
Patent DK-0952965-T3 (DK)
Inventor: NAKANISHI KAZUKI
IPC: B01J20/28
Filed: 1997-12-12
Granted: 2003-01-27
Abstract: A novel method for producing porous inorganic materials, in which the pore sizes in the porous inorganic materials to be produced and also the pore size distribution therein can be freely controlled, is disclosed. The use of precursors of matrix dissolving agents or thermolyzable compounds, such as urea, formamide, N-methylformamide, N,N-dimethylformamide, acetamide, N-methylacetamide or N,N-dimethylacetamide is disclosed.
Patent DK-0975214-T3 (DK)
Inventor: DOTTORI SECONDO
IPC: C12N5/02
Filed: 1998-04-15
Granted: 2004-05-10
Abstract: Cell membrane maintenance of red blood cells and platelet concentrates is improved by the addition of 1 mM-10 mM L-carnitine and derivatives. This improvement allows extension of the period of viability of packed red blood cells and platelet concentrations beyond current periods. Additionally, the materials so treated exhibit extended circulation half life upon transfusion to a patient. Improvements in membrane maintenance achieved by this method permit irradiation of sealed containers of blood products so as to substantially sterilize and destroy leukocytes in the same.
Patent DK-1007874-T3 (DK)
Inventor: PHILLIPS RAYMOND JOHN
IPC: F16B2/22
Filed: 1998-05-08
Granted: 2004-04-26
Abstract: A rod-engaging support device (<HIL><PDAT>1</BOLD><PDAT>) is formed from plastics material. The body (<HIL><PDAT>2</BOLD><PDAT>) of the device (<HIL><PDAT>1</BOLD><PDAT>) supports a fitting e.g. rod connector, suspension hook or munsen ring, which fitting may be integral or removably securable thereto. The device (<HIL><PDAT>1</BOLD><PDAT>) further incorporates rod engagement means (<HIL><PDAT>4, 5</BOLD><PDAT>) wherein the rod is received by the engagement means (<HIL><PDAT>4, 5</BOLD><PDAT>) in a first position and following relative rotation of the device (<HIL><PDAT>1</BOLD><PDAT>) with respect to the rod, the rod is gripped by the engagement means (<HIL><PDAT>4, 5</BOLD><PDAT>) in a second position.</PTEXT>
Patent DK-1021630-T3 (DK)
Inventor: KINTSCHER MATTHIAS
IPC: E04G21/12
Filed: 1998-07-03
Granted: 2002-05-21
Abstract: The invention relates to a device enabling reinforced concrete elements (1, 2) to be linked by means of metal cables, certain portions of which are inserted into the just made concrete (1) while the cable portions which are not inserted protrude into the enclosure formed by the second contiguous concrete element (2). The first concrete element (1) presents a reinforcement which terminates in the area of contact with the second concrete element (2). In parallel or extension to said reinforcement of the first concrete element, pieces of metal cable (4) are inserted so as to provide either spaces for locating the cable free ends in the first concrete element, or passages in the enclosure formed by said first concrete element.
Patent DK-1051180-T3 (DK)
Inventor: COHEN PAUL S
IPC: A61K8/55
Filed: 1998-11-20
Granted: 2002-08-19
Abstract: A pharmaceutical formulation for stimulating growth of Gram-positive Bacilli and increasing the acidity in vagina comprises sucrose and/or maltose, optionally with other sugars, viscous base, and anti-fungal and/or anti-bacterial agents.
Patent DK-1039798-T3 (DK)
Inventor: SCHULTE KLAUS
IPC: A01J5/08
Filed: 1998-12-18
Granted: 2003-05-26
Abstract: The invention refers to a teatcup liner device for a teatcup (1). The teatcup liner device is arranged to be disposed in a teatcup shell (2) of the teatcup in such a way that a pulsation chamber (4) is formed between the teatcup liner device and the teatcup shell. The teatcup liner device comprises a teatcup liner (3), defining an inner space (6) and comprising an upper end portion (7), with an inlet passage (9) extending to the inner space, and a lower end portion (8). The teatcup liner (3) is arranged to receive a teat, which extends through the inlet passage into the inner space. The lower end portion (8) of the teatcup liner forms two outlet passages (10, 11) which extend from the inner space (6) and are arranged to discharge milk from the inner space. The invention also refers to a mould and a method for manufacturing a teatcup liner.
Patent DK-1013647-T3 (DK)
Inventor: SAIKALI ELIE DR
IPC: A61P31/12
Filed: 1999-12-15
Granted: 2003-03-10
Abstract: A halogenated hydrocarbon solvent is used in the production of 2,5-diamino-4,6-dihalo-pyrimidines (I) by reaction of 2,5-diamino-4,6-dihydroxy-pyrimidine (II) or its salts with a phosphorus oxyhalide and a quaternary ammonium halide. A halogenated hydrocarbon solvent is used in the production of 2,5-diamino-4,6-dihalo-pyrimidines of formula (I) by reaction of 2,5-diamino-4,6-dihydroxy-pyrimidine of formula (II) or its salts with a phosphorus oxyhalide and a quaternary ammonium halide. X = halo.
Patent ES-2231088-T3 (ES)
Title: Dispositivo de suspension de carteles.
Inventor: SCHONING MICHAEL
IPC: G09F15/00
Filed: 2000-07-22
Granted: 2005-05-16
Abstract: Dispositivo de suspensión de carteles que comprende una banda de carteles (7) trasladable en vaivén entre dos rodillos (1, 2) superpuestos a distancia uno de otro - bajo tensión longitudinal en la dirección de transporte (8) del rodillo (1) al rodillo (2) -, estando asociados a los cantos longitudinales laterales (9, 10) de la banda de carteles (7) que se extienden en la dirección de transporte (8), en la zona entre los rodillos (1, 2), unos medios de retención (11, 12) - que se extienden de un rodillo a otro - en calidad de guía lateral de la banda de carteles (7), caracterizado porque los medios de retención (11, 12) están constituidos por cabezas de guía individuales (15, 16) dispuestas a distancia una de otra en las superficies (13, 14) de la banda de carteles (7), y porque enfrente de cada cabeza de guía (15) vuelta hacia una superficie (13) de la banda de carteles (7) está montada una cabeza de guía (16) en la otra superficie (14) de la banda de carteles para formar así un par (19) decabezas de guía.
Patent ES-2251354-T3 (ES)
Inventor: CASSINA VIRGINIO
IPC: B65D77/06
Filed: 2000-05-15
Granted: 2006-05-01
Abstract: The pallet comprises a platform (12) formed by a hollow, unitary body having two opposed major walls on which there are corresponding inwardly-extending ribs (16) which are welded together. Projecting portions (17, 18, 19) of the platform (12) are welded to corresponding base elements (13) which are also formed, in threes, by hollow unitary bodies. The resulting structure is particularly stiff and can advantageously be produced by an extrusion-blowing process with plastics material of high molecular weight. <IMAGE>   <IMAGE>